[Current possibilities of correction of hormonal imbalance in uremia].
The authors' and literature data on hormonal imbalance in uremia are analysed. The pathogenesis, clinical and laboratory signs and present-day methods of correction of renal osteodystrophy, anemia, arterial hypertension, derangements of carbohydrate and lipid metabolism, and hypogonadism developing as complications of chronic renal insufficiency (CRI), are considered. Increased potentialities of pharmacological correction of the above endocrine disturbances in CRI have been shown.
Ermolenko
V M
VM
Nikiforova
N V
NV
Kukhtevich
A V
AV
Lifshits
N L
NL
Strunin
S E
SE
D000328:Adult; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D002117:Calcitriol / Q000627:therapeutic use; D050260:Carbohydrate Metabolism; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D007006:Hypogonadism / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000628:therapy; D050356:Lipid Metabolism; D008297:Male; D006435:Renal Dialysis / Q000009:adverse effects*; D014511:Uremia / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology
D000959:Antihypertensive Agents; D001971:Bromocriptine; D002117:Calcitriol
Sovremennye vozmozhnosti korrektsii gormonal'nykh narusheniĭ pri uremii.